Search results
Results from the Health.Zone Content Network
A maternal RSV vaccine, given during RSV season to people who are 32–36 weeks pregnant, can also protect babies once they are born. To offer protection to the baby, the mother must receive the ...
The FDA said to avoid the possibility, the vaccine should be given only between 32 weeks and 36 weeks of pregnancy, a few weeks later than during the clinical trial.
Researchers found that when pregnant people received the Abrysvo vaccine during weeks 32–36 of pregnancy, it reduced their baby’s risk of lower respiratory tract disease from RSV by 34.7% ...
In August 2023, the Food and Drug Administration (FDA) approved an RSV vaccine during pregnancy at 32–36 weeks of gestation. The main goal of this vaccine is to help prevent severe RSV in ...
Jan. 25, 2024 -- If pregnant women are given the flu vaccine, their newborns are less likely to need emergency care or to be hospitalized for the flu, according to a new study. Seven hospitals ...
The National Vaccine Injury Compensation Program – which covers most vaccines -- allows people to file a petition if they believe they’ve been hurt by one. According to statistics from the ...
A number of vaccines, especially live-virus vaccines, should not be given to pregnant women, because they may be harmful to the baby. (A live-virus vaccine is made using the live strains of a virus.)
V. ATC code J07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.